×

BLUEBIRD BIO, CELGENE CAR-T THERAPY LEADS TO COMPLETE REMISSION IN 56 PCT OF MULTIPLE MYELOMA PATIENTS -STUDY

BLUEBIRD BIO, CELGENE CAR-T THERAPY LEADS TO COMPLETE REMISSION IN 56 PCT OF MULTIPLE MYELOMA PATIENTS -STUDY